Cargando…

The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials

In two large clinical trials (ZOE-50 [NCT01165177] and ZOE-70 [NCT01165229]), two doses of the adjuvanted recombinant zoster vaccine (RZV) demonstrated >90% efficacy (VE) against herpes zoster (HZ) in adults ≥50 years of age (YOA). This post-hoc analysis assessed the VE against HZ and postherpeti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Joon Hyung, Diaz-Decaro, John, Jiang, Ning, Hwang, Shinn-Jang, Choo, Eun Ju, Co, Maribel, Hastie, Andrew, Hui, David Shu Cheong, Irimajiri, Junya, Lee, Jacob, Leung, Edward Man-Fuk, Tang, Haiwen, Tsuru, Tomomi, Watson, Philip, Wu, Zhenhua, Yu, Chong-Jen, Yuan, Yanfei, Zahaf, Toufik, Cunningham, Anthony L., Schuind, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189096/ https://www.ncbi.nlm.nih.gov/pubmed/33606577 http://dx.doi.org/10.1080/21645515.2020.1859321

Ejemplares similares

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70
por: Boutry, Céline, et al.
Publicado: (2021)

8. The Adjuvanted Recombinant Zoster Vaccine (RZV) Confers Long-term Protection Against Herpes Zoster: Interim Results of an Extension Study (ZOSTER-049) of Two Clinical Trials (ZOE-50 and ZOE-70)
por: Boutry, Céline, et al.
Publicado: (2020)

5. How Does Frailty Impact the Efficacy, Reactogenicity, Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine? A Secondary Analysis of the ZOE-50 and ZOE-70 Studies
por: Andrew, Melissa K, et al.
Publicado: (2020)

E syzygike zoe /
por: Pitol, Sergio, 1933-2018
Publicado: (2007)

Alex et Zoé : et compagnie /
por: Samson, Colette
Publicado: (2000)

Alex et Zoé : á Paris : cahier de lecture.
por: Samson, Colette
Publicado: (2005)

Alex et Zoé et compagnie : méthode de français.
por: Samson, Colette
Publicado: (2005)

Alex et Zoé et compagnie. livre de l'éléve /
por: Samson, Colette
Publicado: (2001)

El retrato de Zoe y otras mentiras
por: Elizondo, Salvador, 1932-2006
Publicado: (1969)

Zingiber officinale Extract (ZOE) Incorporated with Layered Double Hydroxide Hybrid through Reconstruction to Preserve Antioxidant Activity of ZOE against Ultrasound and Microwave Irradiation
por: Kim, Hyoung-Jun, et al.
Publicado: (2019)

Comparing Coronal Discoloration Between AH26 and ZOE Sealers
por: Zare Jahromi, Maryam, et al.
Publicado: (2011)

First person – Emily Jones, Zoe Matthews and Lejla Gul
Publicado: (2019)

Postprandial and Fasting Metabolic Signatures: Insights From the ZOE PREDICT 1 Study
por: Linenberg, Inbar, et al.
Publicado: (2022)

Menopause is associated with postprandial metabolism, metabolic health and lifestyle: The ZOE PREDICT study
por: Bermingham, Kate M., et al.
Publicado: (2022)

Alternative reproductive strategies in black-winged territorial males of Paraphlebia zoe (Odonata, Thaumatoneuridae)
por: Rivas-Torres, Anais, et al.
Publicado: (2019)

Social Jetlag Is Associated With Poor Diet and Increased Inflammation in the ZOE PREDICT 1 Cohort
por: Bermingham, Kate, et al.
Publicado: (2022)

Characterisation of Fasting and Postprandial NMR Metabolites: Insights from the ZOE PREDICT 1 Study
por: Bermingham, Kate M., et al.
Publicado: (2023)

Microleakage and Micrographic Evaluation of Composite Restorations with Various Bases over ZOE Layer in Pulpotomized Primary Molars
por: Bargrizan, M., et al.
Publicado: (2011)

Menopause Is a Key Factor Influencing Postprandial Metabolism, Metabolic Health and Lifestyle: The ZOE PREDICT Study
por: Bermingham, Kate, et al.
Publicado: (2022)

Once again on the Empress Zoe: Women, dermatology, cosmetics, and materia medica (medical matter) in the ancient world
por: Cilione, Marco, et al.
Publicado: (2022)

Exploring the Materials and Condition of 20th-Century Dolls in Zoe Leonard’s Mouth Open, Teeth Showing 2000
por: Lee, Judith, et al.
Publicado: (2022)

Cohort Profile: ZOE 2.0—A Community-Based Genetic Epidemiologic Study of Early Childhood Oral Health
por: Divaris, Kimon, et al.
Publicado: (2020)

Exploring the relationship between social jetlag with gut microbial composition, diet and cardiometabolic health, in the ZOE PREDICT 1 cohort
por: Bermingham, Kate M., et al.
Publicado: (2023)

The Influence of Zinc Oxide Eugenol (ZOE) and Glass Ionomer (GI) Base Materials on the Microhardness of Various Composite and GI Restorative Materials
por: Itskovich, Roee, et al.
Publicado: (2014)

COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study
por: Menni, Cristina, et al.
Publicado: (2022)

Potential public health impact of the adjuvanted recombinant zoster vaccine among people aged 50 years and older in Beijing
por: Lee, Christa, et al.
Publicado: (2021)

Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials
por: Dagnew, Alemnew F, et al.
Publicado: (2020)

Evaluación de las pulpectomías con ZOE realizadas en una clínica particular de especialidades odontológicas de la ciudad de Veracruz, Ver.
por: Chagoya Luna, Guillermo Arturo
Publicado: (2007)

Optimised Glucose “Time in Range” Using Continuous Glucose Monitors in 4,805 Non-Diabetic Individuals Is Associated With Favourable Diet and Health: The ZOE PREDICT Studies
por: Berry, Sarah, et al.
Publicado: (2022)

2780. Reactogenicity Profile of Adjuvanted Recombinant Zoster Vaccine after Dose 2 According to the Intensity of the Same Event Experienced after Dose 1
por: Colindres, Romulo, et al.
Publicado: (2019)

Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials
por: Colindres, Romulo, et al.
Publicado: (2020)

2779. Efficacy of the Adjuvanted Recombinant Zoster Vaccine According to Sex, Geographic Region, and Geographic Ancestry/Ethnicity: A Post-hoc Analysis
por: Willer, David O, et al.
Publicado: (2019)

Evaluación de las pulpectomías con zoe realizadas en la E.O.I de la Facultad de Odontología de la ciudad de Xalapa, Universidad Veracruzana/
por: Ibáñez Juárez, Rosalía Isolda
Publicado: (2004)

Preventive efficacy of six monthly oral doses of Simparica Trio(®), Heartgard(®) Plus, and Interceptor(®) Plus against a macrocyclic lactone-resistant strain (ZoeLA) of heartworm (Dirofilaria immitis) in dogs
por: Myers, Jamie A. E., et al.
Publicado: (2022)

Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ/su): A phase-I, open-label study in Japanese adults
por: Lal, Himal, et al.
Publicado: (2013)

Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study
por: Menni, Cristina, et al.
Publicado: (2022)

2778. Impact of Reactogenicity on Quality of Life and Physical Functioning in Adults ≥50 Years Receiving Both Doses of the Adjuvanted Recombinant Zoster Vaccine
por: Schmader, Kenneth E, et al.
Publicado: (2019)

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older
por: Cunningham, Anthony L, et al.
Publicado: (2018)

Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster Vaccine
por: Callegaro, Andrea, et al.
Publicado: (2021)

Epidemiology of herpes zoster among adults aged 50 and above in Guangdong, China
por: Zhu, Qi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1nm4mp3hql1ok1n15b2a6b16km